No Data
No Data
No Data
No Data
No Data
Piper Sandler Sticks to Its Buy Rating for Akebia Therapeutics (AKBA)
TipRanksApr 26 19:50
Averoa Seeks EU Approval for Chronic Kidney Disease Drug
France-based Averoa filed a marketing authorization application to the European Medicines Agency for its AVA1014 drug to treat complications associated with chronic kidney disease. The biopharmaceutic
MT NewswiresApr 23 19:36
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersIN8bio (NASDAQ:INAB) stock increased by 47.7% to $1.61 during Wednesday's pre-market session. The market value of their outstanding shares is at $69.6 million. Jaguar Health (NASDAQ:JAGX) share
BenzingaApr 10 20:09
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease,...
PR NewswireApr 3 04:05
12 Health Care Stocks Moving In Friday's Intraday Session
GainersAvalo Therapeutics (NASDAQ:AVTX) shares increased by 364.8% to $22.08 during Friday's regular session. The market value of their outstanding shares is at $17.6 million. Nexalin Technology (NASD
BenzingaMar 30 00:30
Akebia Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Akebia Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow JonesMar 29 00:29
No Data
No Data